Ian Carroll, PhD
Division of Gastroenterology and Hepatology,
Center for Gastrointestinal Biology and Disease (CGIBD),
Chapel Hill, North Carolina
The goals of the Carroll Lab are to determine the mechanisms through which the intestinal microbiota or its metabolites influence gastrointestinal physiology, behavior and adiposity/weight regulation with a view to developing novel nutritional-based therapies for disease.
Dr. Carroll's laboratory uses molecular techniques to characterize the intestinal microbiota in both human and mouse models of nutritional-based diseases. Our investigations ultimately will contribute to understanding host-microbe interactions, where the knowledge gained can be applied to enhance health and reduce illness.
Speaker Disclosure Statement:
Ian Carroll, PhD, has disclosed that he has served as a consultant for Salix Pharmaceuticals and Vivelix, he has a collaboration with OpenBiome.